Media Home / Growth hormone overview / Growth hormone therapy Growth hormone therapy Understanding growth hormone therapy Our products Growth hormone therapy Novo Nordisk A/S is one of the world's leading manufacturers of recombinant human growth hormone. Human growth hormone Human growth hormone is used to treat a variety of conditions in children and adults. It is prescribed to people who do not produce adequate levels of growth hormone on their own and is identical to what the body produces naturally. Research into growth disorders Novo Nordisk is dedicated to furthering research into growth disorders and their treatment. We provide numerous services to help patients undergoing growth hormone treatment and their parents to live life to the full. Through an on-going dialogue with people who use our products and services, we constantly strive to improve the quality of what we offer. UK/WB/1013/0033 October 2013 The Novo Nordisk Way described who we are, where we want to go and how we work. Read more Accessibility Novo Nordisk UK Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Other NN websites novonordiskfoundation.co.uk An independent charitable organisation supporting diabetes research. changingdiabetesresearch.co.uk Novo Nordisk Volunteer Outreach Programme - putting researchers in touch with people who are interested in taking part in research. novonordiskpro.co.uk Novo Nordisk Pro UK is an online service which provides a range of Novo Nordisk product information, clinical reprints, patient support materials and other resources for healthcare professionals working in diabetes. novonordisk-trials.com This website contains information about all Novo Nordisk sponsored clinical trials. ® 2013 Novo Nordisk Ltd Disclaimer / Cookie policy